COVID‐19 vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine‐borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID‐19 pandemic.

Vaccination hesitancy and the “myth” on mRNA‐based vaccines in Italy in the COVID‐19 era: does urgency meet major safety criteria?

Chirumbolo, Salvatore
2021-01-01

Abstract

COVID‐19 vaccination campaign in Italy has started with a huge perplexity about vaccine efficacy, vaccine‐borne adverse effects and vaccine clinical trial studies. In this commentary I tried to elucidate these issues, which represent a fundamental topic to be thoroughly addressed in COVID‐19 pandemic.
2021
Political science
Administrative law
Coronavirus
Public policy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1038588
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 19
social impact